NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, Genmab and Zealand Pharma received new price
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week was full of exciting news. Genmab announced
In the past week, the mobility and food & beverage sectors did well. Especially the fishing stocks had a good performance, and if the fishing
The CO2 & Carbon Capture sector stood out as the best-performing sector in the past week. Multiple companies entered into new collaborations, agreements on expansion
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week Genmab announced a USD 1.8 Billion acquisition
Several sectors had strong performance the past week with almost 10% increases. Aker Carbon Capture rose following a major joint venture/merger, and NEL received MUSD
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week was influenced by easter with only 3.5
The majority of the impact sectors were in positive territory and the average return was 1.6%. The waste management sector had a strong performance following
The Power2X & Fuel Cells sector stood out as the best-performing sector in the past week. As we have seen before, many of the stocks
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week was driven by insider trades in Gubra,
Kapital Partner performs or has within the last 12 months performed corporate finance, market relations, investor relations, Certified Adviser or other advisory activities for the following listed companies: NORD.investments, Biosergen, InterMail, Pila Pharma, Hypefactors, Curasight, Evaxion, Re-Match, Audientes, Mdundo.com, Nexcom.
Del indlægget på sociale media eller på email.